About Oramed
Oramed is a company based in Jerusalem (Israel) founded in 2006.. The company has 13 employees as of December 31, 2024. Oramed offers products and services including ORMD-0801 and ORMD-0901. Oramed operates in a competitive market with competitors including Sana Biotechnology, Semma Therapeutics, Adocia, Rezolute and Cellino, among others.
- Headquarter Jerusalem, Israel
- Employees 13 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Oramed Pharmaceuticals Inc.
-
Annual Revenue
$0-100as on Dec 31, 2024
-
Net Profit
$-19.06 M-444.98as on Dec 31, 2024
-
EBITDA
$-12.59 M19.17as on Dec 31, 2024
-
Latest Funding Round
$55.29 K (USD), Grant
Mar 31, 2020
-
Investors
European Union
& 1 more
-
Employee Count
13
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Oramed
Oramed is a publicly listed company on the NASDAQ with ticker symbol ORMP in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Oramed
Oramed offers a comprehensive portfolio of products and services, including ORMD-0801 and ORMD-0901. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Oral capsule for treating diabetes and NASH conditions
Oral therapy for metabolic disorders like diabetes
Unlock access to complete
Unlock access to complete
Funding Insights of Oramed
- Total Funding Total Funding
- Total Rounds 6
- Last Round Grant — $55,285
-
First Round
First Round
(13 Apr 2011)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2020 | Amount | Grant - Oramed | Valuation |
investors |
|
| Dec, 2019 | Amount | Grant - Oramed | Valuation |
investors |
|
| Jul, 2018 | Amount | Post-IPO - Oramed | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Oramed
Oramed has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union and EIC Fund. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Founded Year | Domain | Location | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Oramed
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Oramed
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Oramed Comparisons
Competitors of Oramed
Oramed operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sana Biotechnology, Semma Therapeutics, Adocia, Rezolute and Cellino, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Genetically engineered cell therapies are developed for multiple disorders.
|
|
| domain | founded_year | HQ Location |
Provider of bio-artificial pancreas for Type 1 Diabetes treatment
|
|
| domain | founded_year | HQ Location |
Therapeutics for diabetes and obesity treatment are developed.
|
|
| domain | founded_year | HQ Location |
Therapies for metabolic and orphan diseases are developed by Rezolute.
|
|
| domain | founded_year | HQ Location |
Developer of autologous cell therapies
|
|
| domain | founded_year | HQ Location |
Innovates long-acting oral therapies to simplify patient medication regimens.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Oramed
Frequently Asked Questions about Oramed
When was Oramed founded?
Oramed was founded in 2006 and raised its 1st funding round 5 years after it was founded.
Where is Oramed located?
Oramed is headquartered in Jerusalem, Israel. It is registered at Jerusalem, Jerusalem District, Israel.
How many employees does Oramed have?
As of Dec 31, 2024, the latest employee count at Oramed is 13.
What does Oramed do?
Oramed was founded in 2006 in Jerusalem, Israel, and operates in the biotechnology sector focused on oral drug delivery. Proprietary POD technology is utilized to shield proteins from gastrointestinal enzymatic degradation and enhance intestinal absorption. The pipeline features ORMD-0801, targeted at type-2 and type-1 diabetes, along with an oral version of Exenatide, a glucagon-like peptide-1 analog designed to promote insulin secretion.
Who are the top competitors of Oramed?
Oramed's top competitors include Sana Biotechnology, Semma Therapeutics and Adocia.
What products or services does Oramed offer?
Oramed offers ORMD-0801 and ORMD-0901.
Is Oramed publicly traded?
Yes, Oramed is publicly traded on NASDAQ under the ticker symbol ORMP.
Who are Oramed's investors?
Oramed has 2 investors. Key investors include European Union, and EIC Fund.
What is Oramed's ticker symbol?
The ticker symbol of Oramed is ORMP on NASDAQ.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.